Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6075)
All Articles published online
|
Feb 26, 2010 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Biological Chemistry
ISSN
1949-8454
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
dos Santos ALS. HIV aspartyl protease inhibitors as promising compounds against |
|---|---|
| URL: | https://www.wjgnet.com/1949-8454/full/v1/i2/21.htm |
| Number | Citing Articles |
| 1 |
Sławomir Milewski. Candida albicans: Cellular and Molecular Biology. 2017; : 429 doi: 10.1007/978-3-319-50409-4_21
|
| 2 |
Mariusz Gogol, Oliwia Bochenska, Marcin Zawrotniak, Justyna Karkowska-Kuleta, Dorota Zajac, Maria Rapala-Kozik. Pathophysiological Aspects of Proteases. 2017; : 353 doi: 10.1007/978-981-10-6141-7_15
|
| 3 |
Letícia Silveira Goulart, Werika Weryanne Rosa de Souza, Camila Aoyama Vieira, Janaina Sousa de Lima, Ricardo Alves de Olinda, Claudinéia de Araújo. Oral colonization by Candida species in HIV-positive patients: association and antifungal susceptibility study. Einstein (São Paulo) 2018; 16(3) doi: 10.1590/s1679-45082018ao4224
|
| 4 |
Shanthini Kalimuthu, Om Alkhir Alshanta, Akshaya Lakshmi Krishnamoorthy, Akhila Pudipeddi, Adline Princy Solomon, William McLean, Yiu Yan Leung, Gordon Ramage, Prasanna Neelakantan. Small molecule based anti-virulence approaches against Candida albicans infections. Critical Reviews in Microbiology 2022; 48(6): 743 doi: 10.1080/1040841X.2021.2025337
|
| 5 |
Karina M. Rebello, Valter V. Andrade-Neto, Claudia Regina B. Gomes, Marcos Vinícius N. de Souza, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos, Claudia M. d'Avila-Levy. Miltefosine-Lopinavir Combination Therapy Against Leishmania infantum Infection: In vitro and in vivo Approaches. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00229
|
| 6 |
Marjan A. Rafiee. Anti‐Coronavirus Activity of Certain Herbacetin Derivatives, A Theoretical Study. ChemistrySelect 2024; 9(15) doi: 10.1002/slct.202303477
|
| 7 |
Vishnu Menon, Mala Rao. A low-molecular-mass aspartic protease inhibitor from a novel Penicillium sp.: implications in combating fungal infections. Microbiology 2012; 158(7): 1897 doi: 10.1099/mic.0.058511-0
|
| 8 |
Om Alkhir Alshanta, Khawlah Albashaireh, Emily McKloud, Christopher Delaney, Ryan Kean, William McLean, Gordon Ramage. Candida albicans and Enterococcus faecalis biofilm frenemies: When the relationship sours. Biofilm 2022; 4: 100072 doi: 10.1016/j.bioflm.2022.100072
|
| 9 |
Małgorzata Bondaryk, Zbigniew Ochal, Monika Staniszewska. Comparison of anti-Candida albicans activities of halogenomethylsulfonyl derivatives. Medicinal Chemistry Research 2015; 24(5): 1799 doi: 10.1007/s00044-014-1258-8
|
| 10 |
André L. S. Santos, Lys A. Braga-Silva, Bianca A. Silva, Vanila F. Palmeira, Roberta S. Valle, Érika A. Abi-chacra, Vanessa S. Oliveira, Roberto D. Lins, Lucimar F. Kneipp, Cátia L. Sodré. Proteases in Health and Disease. 2013; : 89 doi: 10.1007/978-1-4614-9233-7_7
|
| 11 |
J.J.C. Sidrim, L.V. Perdigão-Neto, R.A. Cordeiro, R.S.N. Brilhante, J.J.G. Leite, C.E.C. Teixeira, A.J Monteiro, R.M.F. Freitas, J.F. Ribeiro, J.R.L. Mesquita, M.V.F. Gonçalves, M.F.G. Rocha. Viral protease inhibitors affect the production of virulence factors inCryptococcus neoformans. Canadian Journal of Microbiology 2012; 58(7): 932 doi: 10.1139/w2012-075
|
| 12 |
Cristina Nicoleta Ciurea, Irina-Bianca Kosovski, Felicia Toma, Mihai Mareș, Bianca Tudor, Adrian Man. Mediation of Candida species growth and virulence by the proinflammatory cytokine IL-6. Acta Marisiensis - Seria Medica 2021; 67(4): 204 doi: 10.2478/amma-2021-0036
|
| 13 |
Raimunda Sâmia Nogueira Brilhante, José Alexandre Telmos Silva, Géssica dos Santos Araújo, Vandbergue Santos Pereira, Wilker Jose Perez Gotay, Jonathas Sales de Oliveira, Glaucia Morgana de Melo Guedes, Waldemiro Aquino Pereira-Neto, Débora de Souza Collares Maia Castelo-Branco, Rossana de Aguiar Cordeiro, José Júlio Costa Sidrim, Marcos Fábio Gadelha Rocha. Darunavir inhibits Cryptococcus neoformans/Cryptococcus gattii species complex growth and increases the susceptibility of biofilms to antifungal drugs. Journal of Medical Microbiology 2020; 69(6): 830 doi: 10.1099/jmm.0.001194
|
| 14 |
Rossana de Aguiar Cordeiro, Rosana Serpa, Patrícia Bruna Leite Mendes, Antonio José de Jesus Evangelista, Ana Raquel Colares Andrade, Jônatas da Silva Franco, Vandbergue dos Santos Pereira, Lucas Pereira de Alencar, Jonathas Sales de Oliveira, Zoilo Pires de Camargo, Reginaldo Gonçalves de Lima Neto, Débora de Souza Collares Maia Castelo-Branco, Raimunda Samia Nogueira Brilhante, Marcos Fabio Gadelha Rocha, José Júlio Costa Sidrim. The HIV aspartyl protease inhibitor ritonavir impairs planktonic growth, biofilm formation and proteolytic activity inTrichosporonspp.. Biofouling 2017; 33(8): 640 doi: 10.1080/08927014.2017.1350947
|
| 15 |
Amalanathan Veni, T. Sivaswamy Lokeswari, Dhanapal Pavithra, Thennavan Sugapriya. Melianone inhibits Secreted Aspartic Proteases (SAP), a Virulence Factor
During Hyphal Formation in Candida albicans. Current Computer-Aided Drug Design 2022; 18(5): 327 doi: 10.2174/1573409918666220818120645
|
| 16 |
Vanessa V. S. Castilho, Keyla C. S. Gonçalves, Karina M. Rebello, Luiz P. R. Baptista, Leandro S. Sangenito, Helena L. C. Santos, Marta H. Branquinha, André L. S. Santos, Rubem F. S. Menna-Barreto, Ana C. Guimarães, Claudia M. d’Avila-Levy. Docking simulation between HIV peptidase inhibitors and Trypanosoma cruzi aspartyl peptidase. BMC Research Notes 2018; 11(1) doi: 10.1186/s13104-018-3927-z
|
| 17 |
Menizibeya Osain Welcome. Gastrointestinal Physiology. 2018; : 871 doi: 10.1007/978-3-319-91056-7_12
|
| 18 |
Brandon Havranek, Shahidul M. Islam.
An
in silico
approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease
. Journal of Biomolecular Structure and Dynamics 2021; 39(12): 4304 doi: 10.1080/07391102.2020.1776158
|
| 19 |
Karina M. Rebello, Valter V. Andrade-Neto, Aline A. Zuma, Maria Cristina M. Motta, Claudia Regina B. Gomes, Marcus Vinícius N. de Souza, Geórgia C. Atella, Marta H. Branquinha, André L. S. Santos, Eduardo Caio Torres-Santos, Claudia M. d'Avila-Levy. Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism ofLeishmania amazonensispromastigotes. Parasitology 2018; 145(10): 1304 doi: 10.1017/S0031182018000823
|
| 20 |
Rafael M Gandra, Lívia S Ramos, Lucas P S Cruz, Lucieri O P Souza, Marta H Branquinha, André L S Santos.
Candida parapsilosis: Heterogeneous and strain-specific expression of secreted aspartic proteases (Sapp1 and Sapp2). Medical Mycology 2024; 62(7) doi: 10.1093/mmy/myae066
|
| 21 |
André Luis Souza dos Santos. Protease expression by microorganisms and its relevance to crucial physiological/pathological events. World Journal of Biological Chemistry 2011; 2(3): 48-58 doi: 10.4331/wjbc.v2.i3.48
|
| 22 |
Monika Staniszewska, Małgorzata Bondaryk, Zbigniew Ochal. Susceptibility of Candida albicans to New Synthetic Sulfone Derivatives. Archiv der Pharmazie 2015; 348(2): 132 doi: 10.1002/ardp.201400360
|
| 23 |
Wenli Feng, Jing Yang, Yan Ma, Zhiqin Xi, Xiaoqin Zhao, Xiaoxia Zhao, Min Zhao. The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11. Immunity, Inflammation and Disease 2021; 9(3): 667 doi: 10.1002/iid3.415
|
| 24 |
Anmol Kulshrestha, Pratima Gupta. Secreted Aspartyl Proteases Family: A Perspective Review on the Regulation Of Fungal Pathogenesis. Future Microbiology 2023; 18(5): 295 doi: 10.2217/fmb-2022-0143
|
| 25 |
Gunderao Hanumantrao Kathwate, S. Mohan Karuppayil. Antifungal properties of the anti-hypertensive drug: Aliskiren. Archives of Oral Biology 2013; 58(9): 1109 doi: 10.1016/j.archoralbio.2013.02.006
|
| 26 |
Luiz R. Travassos, Carlos P. Taborda. Linear Epitopes of Paracoccidioides brasiliensis and Other Fungal Agents of Human Systemic Mycoses As Vaccine Candidates. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00224
|
| 27 |
Vanila F. Palmeira, Fatima R. V. Goulart, Marcela Q. Granato, Daniela S. Alviano, Celuta S. Alviano, Lucimar F. Kneipp, André L. S. Santos. Fonsecaea pedrosoi Sclerotic Cells: Secretion of Aspartic-Type Peptidase and Susceptibility to Peptidase Inhibitors. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.01383
|
| 28 |
Ayodeji A. Agbowuro, Wilhelmina M. Huston, Allan B. Gamble, Joel D. A. Tyndall. Proteases and protease inhibitors in infectious diseases. Medicinal Research Reviews 2018; 38(4): 1295 doi: 10.1002/med.21475
|
| 29 |
Marcela Q. Granato, Ingrid S. Sousa, Thabatta L. S. A. Rosa, Diego S. Gonçalves, Sergio H. Seabra, Daniela S. Alviano, Maria C. V. Pessolani, André L. S. Santos, Lucimar F. Kneipp. Aspartic peptidase of Phialophora verrucosa as target of HIV peptidase inhibitors: blockage of its enzymatic activity and interference with fungal growth and macrophage interaction. Journal of Enzyme Inhibition and Medicinal Chemistry 2020; 35(1): 629 doi: 10.1080/14756366.2020.1724994
|